Skip to content
Abstract 187: Reversible Aptamer Inhibition of Von Willebrand Factor is a Potent Thrombolytic and Ameliorates Stroke Burden Following Vascular Injury Compared to Recombinant Tissue Plasminogen Activator
Home
About
Leadership
Board of Directors
Scientific and Clinical Advisory Board
Investment Partners
Science
Approach / Novel RNA Aptamer
Mechanism of Action
Pipeline
Thrombosis
Acute Stroke
Our Solution
Clinical Trials
Publications
News
Featured News
Press Releases
Careers
Baskings Australia
Contact
Privacy Policy
Terms of Use
Sitemap
Hamburger Toggle Menu
